Antimicrobials Stewardship by Pharmacist
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02768454|
Recruitment Status : Unknown
Verified May 2016 by National Taiwan University Hospital.
Recruitment status was: Active, not recruiting
First Posted : May 11, 2016
Last Update Posted : May 13, 2016
|Condition or disease||Intervention/treatment|
|Infection||Drug: medical review of controlled broad-spectrum antibiotics|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Appropriate Use of Controlled Broad-spectrum Antimicrobials by Establish Stewardship and Execute by Antibiotic Pharmacist|
|Study Start Date :||September 2015|
|Estimated Primary Completion Date :||September 2016|
|Estimated Study Completion Date :||September 2016|
inpatient under broad-spectrum antibiotics
Drug: medical review of controlled broad-spectrum antibiotics
medical review of outcome of antibiotics stewardship by pharmacists and infectious disease physicians
- The percentage of appropriateness of empirical antibiotics choosing. [ Time Frame: up to 8 weeks ]For example,the inappropriate of piperacillin-tazobactam as empirical therapy was numbers of participants with no risk factors of deep tissue infection or DM foot /Number of participants treated with piperacillin-tazobactam for soft tissue infection.
- The percentage of appropriateness of de-escalation of therapy. [ Time Frame: up to 8 weeks ]For example,continued piperacillin-tazobactam was seen to be inappropriate when microbiologic results and clinical status permit de-escalation.
- Number of adverse events of antibiotics were recorded. [ Time Frame: up to 8 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02768454
|National Taiwan University Hospital|
|Yun-Lin, Dou-Liou, Taiwan, test3|
|Principal Investigator:||Shu-Chen Yang, master||National Taiwan University Hospital, Yun-Lin Branch|